BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
11.15
-0.25 (-2.19%)
At close: Oct 17, 2025, 4:00 PM EDT
11.10
-0.05 (-0.45%)
After-hours: Oct 17, 2025, 4:00 PM EDT
BBOT Employees
BridgeBio Oncology Therapeutics had 62 employees as of December 31, 2024.
Employees
62
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,411,290
Market Cap
883.04M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BBOT News
- 5 days ago - BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 2 months ago - BBOT to Participate in Upcoming September Investor Healthcare Conferences - GlobeNewsWire
- 2 months ago - BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition - GlobeNewsWire